ChemoCommunity

Characterizing chemoresponse communities at transcriptional and post-transcriptional levels.

Compound Details

The detailed records of NSC 686551 were elucidated in the following 4 sections: 1) Basis: basic information about NSC 686551; 2) Community: the network communities that were significantly associated with the response to NSC 686551; 3) Molecule: the relationships between components within communities and NSC 686551; 4) MDR: the compounds that were significantly associated with the NSC 686551.

NSC Compound Enrichment Correlation
NSC 750335 (E)-3-(2-(4-methoxyphenyl)imidazo[1,2-a]pyridin-3-yl)-1-(3,4,5-trimethoxyphenyl)prop-2-en-1-one 0.0112651116880208 0.31528285
NSC 754109 ethyl 8-(3-methoxybenzyl)-5,8-dihydro-4H-isoxazolo[4,5-g]indole-7-carboxylate 0.0112651116880208 0.15892641
NSC 757982 Null 0.0112651116880208 0.11885798
NSC 10848 Null 0.011265111688021 0.076254864
NSC 116693 Null 0.011265111688021 0.2213827
NSC 116878 Cardiac glycoside 0.011265111688021 -0.022969881
NSC 176327 Ellipticine, 6-(3-aminopropyl)-9-methoxy-, dihydrochloride 0.011265111688021 0.045714773
NSC 282880 Ethanaminium, 2-[[hydroxy(octadecyloxy)phosphinyl]oxy]-N,N,N-trimethyl-, inner salt (9CI) 0.011265111688021 0.23371163
NSC 351907 MASTOPARAN 0.011265111688021 0.22930659
NSC 59220 [[5-(5-fluoro-2,4-dioxopyrimidin-1-yl)-3, 4-dihydroxyoxolan-2-yl]methoxy-ydroxyphosphoryl] [3,4,5-trihydroxy-6-(hydroxymethyl)oxan-2-yl] hydrogen phosphate, disodium salt 0.011265111688021 0.20066127
Total:106  Current:28    [First] [Prev] [Next] [Last]